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ABSTRACT
This review explores the beneficial effects of honey on Helicobacter pylori-induced gastric ulcer and duodenal ulcer. 
The research of the effectiveness of honey on H. pylori infection using electronic databases was done, these include 
Medline via Ovid Medline, Scopus and ScienceDirect published from the year 2000 to 2018. The articles were evaluated 
and selected based on the criteria which report on the effects of honey on gastric ulcer and duodenum ulcer caused by 
H. pylori infection. There are 53 articles were identified, which stated to the studies that relate to the criteria. Afterwards, 
nine articles on honey and its extracts were selected and assessed accordingly in this review. All studies reported 
positive effects of honey on H. pylori-induced gastric ulcer and duodenal ulcer. Most of the studies showed at minimum 
10% of honey concentration were effective as anti-H. pylori activity. This systematic review emphasized the potential of 
honey used to inhibit the H. pylori infection in-vitro. Future extensive studies are required to find the active component 
and molecular mechanism of honey before animal and human observational studies could be conducted to deliver valid 
evidence.
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ABSTRAK
Ulasan ini adalah untuk mengkaji kesan manfaat madu pada Helicobacter pylori teraruh ulser gaster dan ulser 
duodenal. Satu kajian terhadap keberkesanan madu pada jangkitan H. pylori menggunakan pangkalan data elektronik 
telah dilakukan, ini termasuklah Medline melalui Ovid Medline, Scopus dan ScienceDirect yang telah diterbitkan dari 
tahun 2000-2018. Artikel telah dinilai dan dipilih berdasarkan kriteria yang melaporkan mekanisme dan kesan madu 
pada ulser gaster dan ulser duodenum yang disebabkan oleh jangkitan H. pylori. Terdapat 53 artikel telah dikenal pasti 
yang merujuk kepada kajian yang sepadan dengan kriteria. Seterusnya, sembilan artikel mengenai madu dan ekstrak 
madu telah dipilih dan dinilai sewajarnya dalam kajian ini. Semua kajian melaporkan kesan positif pada madu terhadap 
H. pylori yang berpunca daripada ulser gastrik dan ulser duodenal. Kebanyakan kajian menunjukkan sekurang-
kurangnya kepekatan madu sebanyak 10% berkesan sebagai aktiviti anti-H. pylori. Kajian sistematik ini menekankan 
potensi madu yang digunakan untuk merencatkan jangkitan H. pylori secara in-vitro. Kajian menyeluruh pada masa 
akan datang adalah perlu untuk mencari komponen aktif dan mekanisme molekul yang ada pada madu sebelum kajian 
pengamatan terhadap haiwan dan manusia dijalankan untuk memberi bukti yang sah.
Kata kunci: Gastritis; Helicobacter pylori; kanser gaster; madu; ulser duodenal; ulser gaster
INTRODUCTION
Helicobacter pylori can be defined as a type of bacterium 
that is classified as gram-negative, flagellated, spiral-
shaped and it produces large amounts of urease enzyme 
that neutralizes the pH inside the bacterial cells. H. pylori 
colonize within the gastrointestinal tract and mucosa layer 
of the stomach lining which causes inflammation and ulcers 
in the stomach or duodenum (Cui et al. 2012; De Monte 
et al. 2015; Eusebi et al. 2014). Chronic infections with H. 
pylori can lead to chronic gastritis, peptic ulcers, gastric 
cancer and mucosa-associated lymphoid tissue lymphoma. 
Although H. pylori infection prevalence had decreased, 
this bacterium still infects 30% to 50% of the general 
population (Altman et al. 2008; Malnick et al. 2014). In 
addition, patients with the severe gastroduodenal disease 
will have a high rate of H. pylori infection (Alfizah et al. 
2010). Finding a good treatment for H. pylori infection has 
always been a very challenging course. The first-line 
regimen to destroy H. pylori comprises of a triple therapy 
which consists of a combination of two of the standard 
antibiotics (clarithromycin and amoxicill in or 
metronidazole) plus a proton pump inhibitor (Malfertheiner 
et al. 2002). However, the effectiveness of the standard 
triple therapy has their limitation, due to the rise in the 
occurrence of antibiotic resistance to H. pylori and the 
noncompliance of patients to treatment routine (Alfizah et 
al. 2014; Gisbert & Calvet 2012; Kanizaj & Kunac 2014).
On the other hand, a lot of in-vitro studies on honey 
have shown positive activities against H. pylori infection 
(Manyi-Loh et al. 2013; Matongo & Nwodo 2014; 
Ruckriemen et al. 2017). Honey has been used as a food 
product and traditional medicine for thousands of years to 
cure a variety of illness because of its healing properties 
(Allsop & Miller 1996; Estevinho et al. 2008). Nowadays, 
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its nutritional and medical values were reevaluated by most 
of the researchers and have been scientifically proven as 
antimicrobial, anti-inflammatory, antioxidant, anticancer 
and antidiabetic effects (Erejuwa et al. 2011, 2010; Othman 
2012; Sherlock et al. 2010). Honey is also reported to be 
active in treating numerous form of microbes related 
disease, comprising gram-positive and negative organisms, 
aerobic and anaerobic bacteria (Ndip et al. 2007; Zaghloul 
et al. 2001). In addition, properties of honey such as pH, 
osmolarity, and mostly it’s peroxidase activity that acted 
as antimicrobial effects (Ghazali 2009; Nasir et al. 2010). 
The existence of non-peroxidase substances such as 
phenolic acids, flavonoids, and lysozymes in honey also 
contribute to their antimicrobial activity (Alnaqdy et al. 
2005; Tan et al. 2009). In summary, the purpose of this 
review is to summarize and to elucidate the importance of 
honey as an anti-H. pylori and to investigate the key 
components on honey against H. pylori-induced gastric 
ulcer and duodenal ulcer disease. In addition, since 
patients’ prevalence is noncompliance to the treatment 
regimen is high (Samie et al. 2007; Tanih et al. 2010), it 
is vital for the world to find a natural and alternative 
treatment to conquer this matter.
MATERIALS AND METHODS
LITERATURE SEARCH STRATEGY
This systematic review was designed and carried out to 
analyse related studies of honey as an alternative to H. 
pylori treatment. For the strategy search of health science 
journals; database from Medline via Ovid Medline, Scopus 
and ScienceDirect were used. The search plan involved in 
this research review is the combination of keywords: 
honey, and Helicobacter pylori OR H. pylori.
INCLUSION AND EXCLUSION CRITERIA
Every article must fit into the inclusion and exclusion 
criteria to be selected. Thus, there are some guidelines 
made specifically for this. The inclusion criteria are: 
Studies written in English and the title and abstracts were 
related to the keywords given. Articles were also included 
if the paper mentioned: Usage of honey as an alternative 
treatment; H. pylori bacteria; and recent articles from the 
year 2000 to 2018. On the other hand, articles will not be 
selected if they were review articles, articles written in 
other languages, combination compound on honey, not 
related to in-vitro study, and duplicate studies.
DATA EXTRACTION AND MANAGEMENT
To complete this search review, three reviewers screened 
the papers and decided for articles selected before the data 
extraction phase. The data collection were systematized 
and all data extraction was performed individually. The 
following data were recorded in this review: name of 
authors; the type and origin of the honey sample; type of 
strain H. pylori; methods of anti-H. pylori activity used; 
and a brief description of the study results.
RESULTS
SEARCH RESULTS
There are 53 collected works found theoretically related 
to the articles after three self-reliant reviewers screened 
the articles’ result according to the title and abstract. In the 
total of those 53 articles; 26 are from Ovid, 21 are from 
Scopus, and 6 from ScienceDirect were saved for further 
evaluation and data extraction. Then, 44 articles were 
excluded and the remaining of 9 articles were selected for 
this systematic review. A flowchart of the selected articles 
was created to represent the study selected as shown in 
Figure 1.
STUDY CHARACTERISTICS
Table 1 shows a summary of the characteristics of the 
overall study. Based on the types of in-vitro studies chosen, 
nine articles on the studies of honey were included in this 
review. To be specific, out of nine honey studies, four 
studies focused on raw natural honey (Abdel-Latif & 
Abouzied 2016; Kim et al. 2015; Ndip et al. 2007; Nzeako 
& Al-namaani 2006), two studies examined on extracted 
honey (Manyi-Loh et al. 2012; Matongo & Nwodo 2014) 
and three other studies demonstrated the effects of raw 
honey and its extraction (Kim et al. 2017; Manyi-Loh et 
al. 2013; 2010)
EFFECT OF HONEY ON Helicobacter pylori
Kim et al.(2017) assessed the anti-H. pylori activity of 
Korean Acacia honey extracted with n-hexane, 
dichloromethane, ethyl acetate, and n-butanol. Results 
showed inhibition zone diameters of 9.2 ± 5.8 mm at 20% 
(v/v) concentration of raw Acacia honey. The ethyl acetate 
extract showed the highest inhibitory activity, with an 
inhibition zone of 8.5 ± 3.1 mm while the rest of solvent 
extracts (n-hexane, dichloromethane, and butanol) failed 
to inhibit the H. pylori at 10 μg/mL concentration. Whereas 
in their previous study in 2015, the authors assessed the 
antimicrobial activity of selected Korean honey on H. 
pylori strain. Results of raw honey showed at 10% (v/v) 
concentration, Chestnut honey had the strongest inhibitory 
activity (3.5±0.7 mm), followed by Linden tree honey 
(2.5±0.4 mm), Snowbell honey (2.4±0.4 mm), Acacia 
honey (2.3±0.4 mm), and Mandarin orange honey (1.6±0.6 
mm). However, when authors tested honey with catalase 
(by removing the hydrogen peroxide) using the same honey 
concentration, they failed to get H. pylori inhibitory effect. 
Abdel-Latif and Abouzied (2016) investigated the 
effect of natural honey and its molecular mechanism thru 
inhibition of nuclear factor-kB (NF-kB) and activator 
protein-1 (AP-1) activation in gastric epithelial cells 
induced by H. pylori. Manuka honey and other commercial 
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A search of the electronic database: 
Medline, Scopus and ScienceDirect 
Identification through database searching (n= 522): 
Medline = 168                   Scopus = 57                ScienceDirect= 297 
Identification through title and abstracts screening (n= 53): 
Medline = 26                  Scopus = 21                      ScienceDirect = 6 
Full text articles obtained (n= 9) 
Medline = 9 
Selected abstracts (n=18): 
Medline =16             Scopus = 2 
Rejection of abstracts based on 
selection criteria (n= 469) 
 Not a primary study 
 Not related with honey and  H. 
pylori infection 
 Not related with in- vitro study 
 Not a review paper 
Articles that did not match 
inclusion and exclusion criteria 
(n= 9) 
Removal of duplicates (n= 35) 
FIGURE 1. Flowchart of selected articles for this review
TABLE 1. Summary of in-vitro studies of honey in relations to the antibacterial activity against Helicobacter pylori
Reference Honey sample H. pylori strain Anti-H. pylori activity method Results
Kim et al. 
(2017)
Acacia honey from Seoul, Korea was 
extracted with;
N-hexane
Dichloromethane
Ethyl acetate (EtOAc)
N-butanol
H. pylori strain ATCC 43526 
(OD540 = 0.5)
Agar well diffusion •Raw honey
Inhibition zone diameters of 9.2 ± 5.8 mm at 20% (v/v) concentration
• Extract honey
At 10 μg/mL concentration, the ethyl acetate extract has the highest 
inhibitory activity 
Hexane, dichloromethane, and butanol extracts did not exhibit any 
activity at this concentration
Abdel-Latif 
& Abouzie 
(2016)
20% solutions of different 
commercial honey brands from Irish:
Pure Acacia 
Boyne Valley
Healy’s Natural
Manuka (from New Zealand)
H. pylori strain 
NCTC 11638  
(6×108 CFU mL-1)
Electrophoretic mobility shift assay 
(EMSA)
Western blotting
• Raw honey
Highest inhibition of NF-kB and AP-1 activation by 20% 
concentration of Manuka honey and other commercialised honey
Honey blocked I kappa B alpha (IkB-α) protein degradation and 
downregulation of cyclooxygenase-2 (COX-2) protein levels at 20% 
concentration of tested raw honey
Kim et al. 
(2015)
Five types of honey from Seoul, 
Korea:
Acacia 
Chestnut 
Linden tree 
Mandarin orange
Snowbell
H. pylori strain ATCC 43526 
(OD540 = 0.5)
Agar well diffusion • Raw honey
Chestnut honey showed the highest inhibition zone diameter at 
3.5±0.7 mm, followed by Linden tree 2.5±0.4 mm, Snowbell 2.4±0.4 
mm, Acacia 2.3±0.4 mm, and Mandarin orange 1.6±0.6 mm at a 
concentration of 10%
Matongo & 
Nwodo (2014)
The chloroform extract of Natural 
honey (HS) from South Africa
Diethyl ether extract of Manuka 
honey (HM) from New Zealand 
H. pylori strain 369C and 
ATCC 43526 as the control 
strain
2.0×108 CFU/mL
H. pylori ureases from sonication and 
measured spectrophotometrically. 
Calculation of urease inhibition by 
comparing the NADH oxidation rate
•Extract honey
The HS extracted with chloroform shown inhibitory activities 48% 
and 42%, while HM extracted with diethyl ether shown 45% and 51% 
inhibitory activity for H. pylori urease 369C and ATCC 43526
Manyi-Loh et 
al. (2013)
Six types of honey from South Africa 
in concentrations 10, 20, 50 and 75 
(%v/v):
Pure Honey (PH)
Citrus blossom (CB)
Goldcrest (GC)
Champagne Royal Train (CRT)
Honeylene (HL)
Heritage (HH)
30 clinical isolated H. pylori 
and ATCC 43526 as control 
strain
 (0.5 McFarland standard = 
1.8×108 cfu/mL)
Hole plate diffusion • Raw honey
Highest inhibition by PH (16.0±7.5 mm), CB (15.5±8.5 mm) and GC 
(13.7±10.0 mm) honey at 75% (v/v) concentration
CRT (12.7±8.6 mm, 56.7%), HL (13.0±9.2 mm, 63.3%) and HH 
(13.1±9.2 mm, 60.0%) honey produced the highest inhibition at 50% 
(v/v) concentration
• Extract honey
All honey extracts demonstrated inhibition range from (14.5-22.2 
mm) mean zone diameter
CRT diethyl ether extract (22.2±6.1 mm) was the most active honey 
extracts
N-hexane extract (15.8±7.9 mm) in PH honey produced less 
antibacterial activity
Manyi-Loh et 
al. (2012)
N-hexane extract of Goldcrest honey 
from South Africa
H. pylori strain PE93A and  
ATCC 43526 as the control 
strain 
(108 CFU/ mL)
Broth microdilution test • Extract honey
5 mg/mL was the lowest MIC50 (best activity) exhibited by GCF3
GCCL, GCF2 and GCF4 also produced the same inhibition at 7.5 mg/
mL
Manyi-Loh et 
al. (2010)
Three types of honey from South 
Africa was diluted with sterile 
distilled water at concentrations 10, 
20, 50 and 75 (%v/v):
Pure honey (PH)
Citrus blossom (CB)
Goldcrest (GC)
honey extracts:
N-hexane, 
Diethyl ether
Chloroform
Ethyl acetate
30 clinical strains H. pylori 
and NCTC11638 as the 
control strain  
(0.5 McFarland standard = 
1.8×108 CFU/mL)
Agar well diffusion technique • Raw honey
All honey tested were most active at 75% v/v
PH (16.0±7.5 mm) had the greatest inhibitory effect followed by CB 
(15.5±8.5 mm) and GC (13.7±10.0 mm)
At 20% (v/v) and 10% (v/v) concentrations, Goldcrest and Pure had 
the weakest activity
• Extract honey
All honey extracts produced ranged 15.8-18.8 mm zone of inhibition
Diethyl ether extract had the strongest inhibitory activity
N-hexane extract had the weakest antibacterial effect 
Ndip et al. 
(2007)
Four types of honey were diluted 
with sterile distilled water at different 
concentrations of 10, 20, 50 and 75% 
(v/v): 
Manuka from New Zealand
Capillano from Australia 
Eco from Kenya
Mountain from Cameroon
15 isolated H. pylori  and 
NCTC 11638 as the control 
strain 
(0.5 McFarland standard = 
1.5×108 CFU/mL)
Disk diffusion assay • Raw honey
At 75% (v/v) concentration, Mountain honey (82.22%) has the 
strongest inhibitory activity, followed by Capillano and Manuka 
honey (75.56%) and Eco-honey (73.36%)
Nzeako & 
Al-namaani 
(2006)
Eight commercial honey from Oman:
Black Forest
Langnese Forest
Langnese Natural Bee
Black Forest
Blossom Bee
Al-Shifa Natural
Al-Nada Clove
Al-Nada Chestnut 
5 isolates of H. pylori and 
Staphylococcus aureus 
NCTC 6571 as the control 
organism 
(1×104 CFU/mL)
Agar well diffusion method • Raw honey
All honey samples produced growth inhibition zones but when 
diluted to 1:2-1:8 produced different zone sizes. 
Black Forest honey produced the highest growth inhibition zone 
followed by Langnese Forest honey and Langnese natural bee honey 
at 1:2 dilution
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honey brands at 20% concentration showed the highest 
inhibition of NF-kB and AP-1 activation. Similarly, at 20% 
concentration of tested raw honey showed inhibition of 
I-kappa-B-alpha (IkB-α) protein degradation and 
downregulates cyclooxygenase-2 (COX-2) protein levels 
in H. pylori-induced infected cells.  Matongo and Nwodo 
(2014) evaluated H. pylori urease inhibition by honey 
fractions took from different geographical areas. They 
found that the inhibitory activities of Natural honey (HS) 
extracted by Chloroform against H. pylori urease (369C 
and ATCC 43526) were 42% and 48% whereas the 
inhibitory activities of Manuka honey (HM) extracted by 
diethyl ether were 45% and 51%, respectively.
Manyi-Loh et al. (2013) evaluated 30 clinical isolates 
of H. pylori on six local honey and its solvent extracts 
(n-hexane, diethyl ether, chloroform and ethyl acetate). 
The six local kinds of honey at the various concentration 
exhibited a variable level of antibacterial activity. The 
utmost inhibitory activities of raw honey when tested at 
75% (v/v) concentration was PH (16.0±7.5 mm, 73.3%), 
followed by CB (15.5±8.5 mm, 70.0%) and GC (13.7±10.0 
mm, 66.7%), whilst at the concentration of 50% (v/v), CRT 
(12.7±8.6 mm, 56.7%), HL (13.0±9.2 mm, 63.3%) and HH 
(13.1±9.2 mm, 60.0%) were utmost active. When the 
authors tested the anti-H. pylori activity with solvent 
extracts, all extracted honey (PH, GC, CRT and HL) 
demonstrated from 14.5-22.2 mm and 53.3-93.35% 
inhibitions. The highest activity of honey solvent extracts 
was diethyl ether in CRT honey (22.2±6.1 mm, 93.3%) 
while n-hexane extract in PH honey (15.8±7.9 mm, 53.3%) 
has the least antibacterial activity.
On the other hand, in 2012, the same authors did 
determine the fraction of GC n-hexane extract to find the 
minimum inhibitory concentrations (MIC) against H. 
pylori strain. Results of extracted honey showed that 
antibacterial assay of MIC50 values ranged from 5 -10 mg/
mL depending on the fractions and the isolates. 5 mg/mL 
was the lowest MIC50 (best activity) shown by Goldcrest 
mobile phase fractions three (GCF3). However, Goldcrest 
chloroform fraction (GCCL), Goldcrest mobile phase 
fractions two (GCF2) and Goldcrest mobile phase 
fractions four (GCF4) showed same inhibitory against the 
test isolates at 7.5 mg/mL (Manyi-Loh et al. 2012). The 
same authors in 2010 also evaluated anti-H. pylori activity 
of three South African honey at four different 
concentrations and used organic solvents to extract the 
antimicrobial components. The raw honey showed the 
utmost active concentration at 75% (v/v), whereas PH 
(16.0±7.5 mm, 73.33%) has the greatest inhibitory 
activity, followed by CB (15.5±8.5 mm, 70%) and GC 
(13.7±10.0 mm, 66.7%). Whereas at 10% and 20% (v/v) 
concentrations, GC and PH have the least. The susceptibility 
testing of all solvent honey extracts inhibits the strains 
with the zone of inhibition 15.8-18.8 mm. Diethyl ether 
(18.8±8.3 mm, 70%) showed the highest extract, while 
n-hexane (15.8±7.9 mm, 53.3%) extract was the least. 
The chloroform (16.9 ± 6.6 mm, 63.3%) and ethyl acetate 
(16.3 ± 7.6 mm, 60%) extract also has great with 
inhibitory activities (Manyi-Loh et al. 2010).
Ndip et al. (2007) evaluated the antimicrobial potential 
of four various raw honey against clinical isolates of H. 
pylori. The findings showed that the four kinds of honey 
selected exhibited antibacterial activity at different 
concentrations were not significant. At the concentration 
of 75% v/v, Mountain honey produced the highest 
inhibition activity at 82.22%, followed by Capillano® and 
Manuka™ honey at 75.56%, and Eco honey at 73.36%. 
Nzeako and Al-namaani (2006) assessed the isolates H. 
pylori on the antibacterial potential of eight samples of 
commercial honey (Black Forest, Langnese Forest, 
Langnese Natural Bee, Black Forest, Blossom Bee, Al-
Shifa Natural, Al-Nada Clove and Al-Nada Chestnut). All 
raw honey samples without dilution produced growth 
inhibition zones of H. pylori with different zone sizes when 
diluted to 1:2–1:8. Honey Black Forest produced the 
highest growth inhibition zone (19 mm), then the Langnese 
Forest honey (17 mm) and lastly the Langnese natural bee 
honey (11 mm) at 1:2 dilution. Overall, most of the authors 
used agar well diffusion method (Dastouri et al. 2008) as 
an antibacterial mechanism of honey. The H. pylori strain 
were spread plated onto Columbia Agar plates and were 
allowed to dry for 3-5 min. After that, using sterile cork 
borer of 6 mm diameter, five wells were punched in each 
agar plate. Lastly, each of 100 µL of honey solution at 
different concentrations was filled in the wells and 
incubated at 37ºC under microaerophilic conditions. The 
test was carried out in triplicate and observed after 2 to 5 
days. The antimicrobial activity was measured in zone 
inhibition of  H. pylori, obtained in mean diameter (mm) 
around each well.
DISCUSSION
This systematic review shows advantageous in-vitro study 
findings on the effects of numerous honey samples as an 
alternative treatment on H. pylori-induced gastric ulcer. 
The differences in honey preparations and honey 
concentrations made it difficult to compare the results 
generated from the studies and reviews. In this review, six 
studies demonstrated the effect of raw honey from different 
sources and shown that they are efficacious in inhibiting 
the growth of H. pylori (Abdel-Latif & Abouzied 2016; 
Kim et al. 2017; 2015; Manyi-Loh et al. 2010; Ndip et al. 
2007; Nzeako & Al-namaani 2006). There are various 
reports on the antibacterial activities of natural honey, that 
is ascribed to its acidity, osmolarity, hydrogen peroxide 
content, and phytochemical components (Mannina et al. 
2015). Raw honey that exists in the beehive is a natural 
sweetener, which is being processed without adding heat. 
It has fructose and glucose as the main component, 
followed by water, ash, proteins and amino acids and trace 
amounts of enzymes, vitamins and other components such 
as phenolic compounds. However, there were companies 
who fraudulent the honey. They manufactured the syrups 
made to imitate the honey (Molan 1996). 
Four studies showed the inhibition of H. pylori with 
crude honey at a minimum of 10% concentration. Both 
studies of Kim et al. (2017, 2015) documented anti-H. 
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pylori activity at a concentration as low as 10% (v/v) in 
their preliminary screening study of crude Korean acacia 
honey and five different floral types of crude honey. 
Authors suggested that the hydrogen peroxide content was 
responsible for the inhibitory effect of five different floral 
kinds of honey from Korea (Kim et al. 2015). Manyi-Loh 
et al. (2010) also documented that their three locally 
produced honey exhibit antibacterial action on local strains 
of H. pylori from concentrations as low as 10% (v/v). 
Similarly, Ndip et al. (2007) observed that honey at 10% 
concentration inhibited the growth of H. pylori isolates. 
This corroborates the previous in-vitro finding, Ali et al. 
(1991) documented at 10 - 20% of natural honey 
concentrations had an inhibitory effect against H. pylori. 
In another preliminary screening study done by  Manyi-Loh 
et al. (2013) of six crude honey varieties obtained at various 
concentrations, it showed anti-H. pylori activity from 11.0 
mm -16.0 mm inhibition zones. Nzeako and Al-namaani’s 
(2006) experiment observed that the highest antibacterial 
activity was natural Black Forest honey, then Langnese 
Forest honey and Langnese natural bee honey at 1:2 
dilution. These authors studies outcome agrees with many 
earlier researchers on observation of in-vitro, in which 
honey own the antibacterial activity against H. pylori (Ali 
et al. 1991; al Somal et al. 1994; McGovern et al. 1999; 
Molan 2001; Osato et al. 1999). Although all of the honey 
selected in this review demonstrated anti-H. pylori activity, 
there was a dissimilarity in the percentage of susceptibilities 
of the bacteria H. pylori to the variant types of honey tested. 
This dissimilarity has been ascribed to the floral sources 
and plant species scavenged by the bees to harvest the 
honey (Yao et al. 2003). Moreover, in view of the source 
of floral honey, its placement in various geographical 
distribution areas might expect to show a discrepancy and 
this will result in biological activities due to variable 
climatic environments in different regions or countries 
(Basson & Grobler 2008).
H. pylori inhabit on gastric cell causes mucosal 
inflammation and gastric cancer through many pathways 
by the transcription factors activation including nuclear 
factor-kB and activator protein-1 activity which modulates 
several cellular processes for the period of inflammation 
and carcinogenesis (Lamb & Chen 2010; Seo et al. 2004). 
Therefore, Abdel-Latif and Abouzied (2016) conducted a 
study which found that honey at 5% concentrations inhibits 
nuclear factor-kB and activator protein-1 with the 
maximum inhibition at 20% concentrations. Remarkably, 
blockage of nuclear factor-kB and activator protein-1 
activities with Shaw’s acacia, Boyne Valley, and Healy’s 
natural honey are as effective as Manuka honey at similar 
concentrations of 10% - 20%. In corroboration with the 
authors’ results, Hussein et al. (2013, 2012) stated that 
Gelam honey from Johor, Malaysia suppressed the nuclear 
translocation and activation of nuclear factor-kB and 
decreased the cytosolic degradation of IkB-α with a 
continuous decreasing of the inflammatory mediators 
COX-2 and TNF-α in both acute and severe inflammation 
rat model.
Honey comes from the plant source and is able to be 
extracted with organic solvents. The active component of 
honey is frequently low but compact after the extraction 
process which resulted in higher activities (Yaoa et al. 
2005). This review also demonstrated five studies of the 
various types of extracted honey (Kim et al. 2017; Manyi-
Loh et al. 2013, 2012, 2010; Matongo & Nwodo 2014), 
which showed noble potentials of inhibition of H. pylori. 
Kim et al. (2017) showed that among the organic solvent 
fractions tested on honey, those obtained from the ethyl 
acetate extract showed the highest activity against H. 
pylori. Meanwhile, Manyi-Loh et al. (2013) demonstrated 
that the CRT honey extracted by diethyl ether was the most 
potent against bacterial activity in the test isolates. In 
addition to the author’s previous study in 2010 on the 
extraction of the most active honey (Pure honey), the highly 
active extract was diethyl ether extract. There was evidence 
of rising of inhibition zone diameter of the extracts that 
showed more activity compared to crude honey. Authors 
suggest that after extraction, the honey components of 
antimicrobial were concentrated (Manyi-Loh et al. 2010). 
These two studies done by Manyi-Loh et al. (2013, 2010) 
agrees with previous researchers that the solvent extracts 
of honey had significant antibacterial activity against gram-
negative bacteria (Abhishek et al. 2010).
In comparison with the previous Manyi-Loh et al. 
(2012) study, they demonstrated anti-H. pylori activities 
of the extracted GC honey with n-hexane solvent fractions 
that gave the difference in antimicrobial activity, the best 
activity was demonstrated by GCF3 with the MIC50 value 
of 5 mg/mL against both isolates. On the other hand, the 
GC or MS analysis of this fraction found out many 
ingredients that are identified as the antioxidant and have 
the antimicrobial capability, which has been formally 
stated by means of another researcher (Jerkovic et al. 
2009). This may suggest that because of the interaction 
of all the phytoconstituents in GCF3 that may lead to the 
antibacterial activity of the fraction and not acetic acid 
only. Moreover, Matongo and Nwodo (2014) evaluated 
the H. pylori urease inhibition by honey fractions showed 
the potential activity of the crude urease extract is higher 
than the purified form. Authors speculate that the crude 
urease might have rendered when associated with other 
molecules, the susceptibility of honey extracts will gain 
more inhibitory activity. Honey had plenty of mechanisms 
that can kill the microbes, its hydrogen peroxide content 
showed to be the main component that acts as an 
antibacterial effect. Additionally, the previous study also 
has shown that organic solvents can extract the non-
peroxidase components of honey (Molan & Russell 
1988). Apart from that, in the aspect of the clinical setting, 
honey might contribute to eliminating H. pylori infection. 
In a study by Boyanova et al. (2015), results showed 
reduced in prevalence of H. pylori infection in honey 
consumer of 150 dyspeptic patients. When patients 
consuming honey more than one day weekly, there were 
positivity result showed by 50.6% lower compared with 
70.8% of the remainder. 
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STRENGTH AND LIMITATION OF THIS REVIEW
The increase of antibiotics resistance in the treatment of 
H. pylori has been one of the major worldwide community 
health issues. It is a challenging problem since the ideal 
treatment of H. pylori infection still stays a critical issue 
even though it has been studied widely. The natural product 
might be useful as an alternative treatment or as an 
adjuvant. Thus, studies on the effects of honey on H. pylori 
infection have shown some promising results in terms of 
their antimicrobial and antioxidant properties. To add, the 
benefit of this review is the focus on the effects of honey, 
which may be beneficial as alternative medications against 
H. pylori infection. Still, there are limitations identified 
when conducting research on honey and H. pylori. Honey 
preparations and sources used were not standardized. The 
honey was collected from different variable climate 
environments. The difference between preparations and 
sources may produce different effects on the inhibition of 
H. pylori, making the generalization of results and outcome 
difficult. Apart from that, since there was variants type of 
H. pylori strains, selection of H. pylori also need to be 
standardized, for instance, H. pylori strain ATCC 43526 
(Kim et al. 2017) versus H. pylori strain NCTC 11638 
(Abdel-Latif & Abouzied 2016). This is because these 
strains were usually collected based on their local 
preparation and availability. Lastly, the technique of 
examining the antimicrobial of H. pylori also was different 
from the selected studies (Manyi-Loh et al. 2012; Matongo 
& Nwodo 2014).
RECOMMENDATIONS
Honey might be among the antibacterial agents to treat H. 
pylori infection. Unlike refined sugars, honey is safe to 
consume for diabetic patients. It is advantageous in 
substituting honey for refined carbohydrates as these results 
were validated from the previous study (Johnson et al. 
2007; Vallianou 2014). Although there are many promising 
numbers of research studies on natural treatment, further 
extensive research is needed to quicken the steps for the 
new nutraceutical drug development. Furthermore, honey 
usage needs to be standardized to allow direct evaluation 
and analysis of the studies. Thus, a more well-designed 
study should be conducted on animal and human which 
focuses on therapeutic effects related to honey as one of 
the future alternative treatment or prevention of H. pylori 
infection. 
CONCLUSION
The evidence in this systematic review showed the validity 
of honey tested has antibacterial properties by inhibiting 
the growth of H. pylori infection. The extraction of a honey 
constituent with in-vitro anti-H. pylori activity deserves 
further exploration in animal and human trials, and may 
eventually become clinically useful. Therefore, this review 
can be a guideline or benchmark to continue the research 
of honey properties to achieve the dietary substance for 
the improvement of anti-H. pylori infection. 
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